Found: 27
Select item for more details and to access through your institution.
Global molecular changes in rat livers treated with RXR agonists: a comparison using transcriptomics and proteomics.
- Published in:
- Pharmacology Research & Perspectives, 2014, v. 2, n. 6, p. n/a, doi. 10.1002/prp2.74
- By:
- Publication type:
- Article
Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
- Published in:
- Oncogene, 2001, v. 20, n. 53, p. 7710, doi. 10.1038/sj.onc.1204941
- By:
- Publication type:
- Article
Efficacy of the farnesyltransferase inhibitor R115777 in a rat mammary tumor model: role of Ha-ras mutations and use of microarray analysis in identifying potential targets.
- Published in:
- Carcinogenesis, 2006, v. 27, n. 7, p. 1420
- By:
- Publication type:
- Article
Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.
- Published in:
- Carcinogenesis, 2006, v. 27, n. 6, p. 1232, doi. 10.1093/carcin/bgi308
- By:
- Publication type:
- Article
4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
- Published in:
- Carcinogenesis, 2005, v. 26, n. 3, p. 571
- By:
- Publication type:
- Article
Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy doseresponse curves and effects on proliferation and apoptosis.
- Published in:
- Carcinogenesis, 2005, v. 26, n. 2, p. 441
- By:
- Publication type:
- Article
Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7, 12-dimethylbenz[a]anthracene-induced mammary cancer in rats.
- Published in:
- Carcinogenesis, 1996, v. 17, n. 6, p. 1305, doi. 10.1093/carcin/17.6.1305
- By:
- Publication type:
- Article
Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer.
- Published in:
- Oncogene, 2005, v. 24, n. 22, p. 3554, doi. 10.1038/sj.onc.1208426
- By:
- Publication type:
- Article
CpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumors.
- Published in:
- Oncogene, 2004, v. 23, n. 22, p. 3990, doi. 10.1038/sj.onc.1207526
- By:
- Publication type:
- Article
Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models.
- Published in:
- Oncogene, 2004, v. 23, n. 21, p. 3841, doi. 10.1038/sj.onc.1207496
- By:
- Publication type:
- Article
Chemoprevention of mammary carcinogenesis in a transgenic mouse model by a-difluoromethylornithine (DFMO) in the diet is associated with decreased cyclin D1 activity.
- Published in:
- Oncogene, 2003, v. 22, n. 17, p. 2568
- By:
- Publication type:
- Article
Chemopreventive efficacy of anethole trithione, N-acetyl-L-cysteine, miconazole and phenethylisothiocyanate in the DMBA-induced rat mammary cancer model.
- Published in:
- International Journal of Cancer, 1997, v. 72, n. 1, p. 95, doi. 10.1002/(SICI)1097-0215(19970703)72:1<95::AID-IJC14>3.0.CO;2-9
- By:
- Publication type:
- Article
Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer.
- Published in:
- Oncology Letters, 2017, v. 14, n. 3, p. 3480, doi. 10.3892/ol.2017.6632
- By:
- Publication type:
- Article
Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity.
- Published in:
- Molecular Nutrition & Food Research, 2011, v. 55, n. 8, p. 1249, doi. 10.1002/mnfr.201100122
- By:
- Publication type:
- Article
Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: Methods and results from the NCI chemoprevention drug development program.
- Published in:
- Journal of Cellular Biochemistry, 1994, v. 56, p. 32, doi. 10.1002/jcb.240560905
- By:
- Publication type:
- Article
Diffusion Weighted Imaging Evaluated the Early Therapy Effect of Tamoxifen in an MNU-Induced Mammary Cancer Rat Model
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064445
- By:
- Publication type:
- Article
Effect of Canthaxanthin on Chemically Induced Mammary Carcinogenesis.
- Published in:
- Oncology, 1991, v. 48, n. 3, p. 239, doi. 10.1159/000226935
- By:
- Publication type:
- Article
Paradigms for primary prevention of ovarian carcinoma.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Hypermethylation patterns in the Fhit regulatory region are tissue specificGlnur Guler and Dimitrios Iliopoulos contributed equally to this work.This article is a US Government work and, as such, is in the public domain in the United States of America.
- Published in:
- Molecular Carcinogenesis, 2005, v. 43, n. 3, p. 175, doi. 10.1002/mc.20100
- By:
- Publication type:
- Article
A comparative analysis of allelic imbalance events in chemically induced rat mammary, colon, and bladder tumors.
- Published in:
- Molecular Carcinogenesis, 1999, v. 24, n. 1, p. 47, doi. 10.1002/(SICI)1098-2744(199901)24:1<47::AID-MC7>3.0.CO;2-B
- By:
- Publication type:
- Article
Effects of Folate Deficiency and Supplementation on Methylnitrosourea-Induced Rat Mammary Tumors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 22, p. 1740
- By:
- Publication type:
- Article
Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 646, doi. 10.3390/cancers15030646
- By:
- Publication type:
- Article
Pharmacometabolomic Pathway Response of Effective Anticancer Agents on Different Diets in Rats with Induced Mammary Tumors.
- Published in:
- Metabolites (2218-1989), 2019, v. 9, n. 7, p. 149, doi. 10.3390/metabo9070149
- By:
- Publication type:
- Article
Evaluation of the STAT3 inhibitor GLG-302 for the prevention of estrogen receptor-positive and -negative mammary cancers.
- Published in:
- Oncology Reports, 2019, v. 42, n. 3, p. 1205, doi. 10.3892/or.2019.7219
- By:
- Publication type:
- Article
Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer models.
- Published in:
- Oncology Reports, 2019, v. 41, n. 1, p. 718, doi. 10.3892/or.2018.6802
- By:
- Publication type:
- Article
Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer models.
- Published in:
- Oncology Reports, 2018, v. 40, n. 3, p. 1545, doi. 10.3892/or.2018.6313
- By:
- Publication type:
- Article
Rosiglitazone, a PPAR gamma agonist: Potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 10, p. 2254, doi. 10.1002/ijc.23765
- By:
- Publication type:
- Article